UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Relationship of low molecular weight fluorophore levels with clinical factors and fenofibrate effects in adults with type 2 diabetes

Scientific reports, 2021-09, Vol.11 (1), p.18708-18708, Article 18708

2021

Volltextzugriff (PDF)

Baseline Circulating FGF21 Concentrations and Increase after Fenofibrate Treatment Predict More Rapid Glycemic Progression in Type 2 Diabetes: Results from the FIELD Study

Clinical chemistry (Baltimore, Md.), 2017-07, Vol.63 (7), p.1261-1270

2017

Volltextzugriff (PDF)

The relationship of fibroblast growth factor 21 with cardiovascular outcome events in the Fenofibrate Intervention and Event Lowering in Diabetes study

Diabetologia, 2015-03, Vol.58 (3), p.464-473

2015

Volltextzugriff (PDF)

Relationship of fibroblast growth factor 21 with baseline and new on-study microvascular disease in the Fenofibrate Intervention and Event Lowering in Diabetes study

Diabetologia, 2015-09, Vol.58 (9), p.2035-2044

2015

Volltextzugriff (PDF)

Comparison of SSCP and DHPLC for the detection of LDLR mutations in a New Zealand cohort

Human mutation, 2002-03, Vol.19 (3), p.311-311

2002

Volltextzugriff (PDF)

Relative glycaemic impact of customarily consumed portions of eighty-three foods measured by digesting in vitro and adjusting for food mass and apparent glucose disposal

British journal of nutrition, 2010-08, Vol.104 (3), p.407-417

2010

Volltextzugriff (PDF)

Comparison of Insulin Resistance, Metabolic Syndrome and Adiponectin in Overweight Bipolar Patients Taking Sodium Valproate and Controls

Australian and New Zealand journal of psychiatry, 2009-01, Vol.43 (1), p.53-60

2009

Volltextzugriff (PDF)

All-Cause Mortality in the Canterbury (New Zealand) Insulin-Treated Diabetic Registry Population

Diabetes care, 2001-01, Vol.24 (1), p.56-63

2001

Volltextzugriff (PDF)

Cause-specific mortality in insulin-treated diabetic patients: A 20-year follow-up

Diabetes research and clinical practice, 2008-04, Vol.80 (1), p.16-23

2008

Volltextzugriff (PDF)

Predictors of mortality from type 2 diabetes mellitus in Canterbury, New Zealand; a ten-year cohort study

Diabetes research and clinical practice, 2001-08, Vol.53 (2), p.113-120

2001

Volltextzugriff (PDF)

Plasma retinol-binding protein is not a marker of insulin resistance in overweight subjects: A three year longitudinal study

Clinical biochemistry, 2008-09, Vol.41 (13), p.1034-1038

2008

Volltextzugriff (PDF)

All-cause mortality in insulin-treated diabetic patients: A 20-year follow-up

Diabetes research and clinical practice, 2008-04, Vol.80 (1), p.e6-e9

2008

Volltextzugriff (PDF)

Homocysteine, glycine betaine, and N, N-dimethylglycine in patients attending a lipid clinic

Metabolism, clinical and experimental, 2005, Vol.54 (1), p.1-14

2005

Volltextzugriff (PDF)

Relationship between plasma coenzyme Q10 , asymmetric dimethylarginine and arterial stiffness in patients with phenotypic or genotypic familial hypercholesterolemia on long-term statin therapy

Atherosclerosis, 2011-09, Vol.218 (1), p.188-193

2011

Volltextzugriff (PDF)

A Randomized, Double-Blind, Placebo-Controlled Crossover Study of Coenzyme Q10 Therapy in Hypertensive Patients With the Metabolic Syndrome

American journal of hypertension, 2012-02, Vol.25 (2), p.261-270

2012

Volltextzugriff (PDF)

Comparative effects of enzogenol® and vitamin C supplementation versus vitamin C alone on endothelial function and biochemical markers of oxidative stress and inflammation in chronic smokers

Free radical research, 2006, Vol.40 (1), p.85-94

2006

Volltextzugriff (PDF)

Variability in measurements of blood glucose response to foods in human subjects is not reduced after a standard breakfast

Nutrition research (New York, N.Y.), 2009-04, Vol.29 (4), p.238-243

2009

Volltextzugriff (PDF)

Considerable temporal variability in glucose reference curves in humans for a year period

Nutrition research (New York, N.Y.), 2008-08, Vol.28 (8), p.495-500

2008

Volltextzugriff (PDF)

PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2015-01, Vol.385 (9965), p.331-340

2015

Volltextzugriff (PDF)

Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease

The New England journal of medicine, 2017-05, Vol.376 (18), p.1713-1722

2017

Volltextzugriff (PDF)

Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease

The New England journal of medicine, 2021-01, Vol.384 (2), p.129-139

2021

Volltextzugriff (PDF)

Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2016-04, Vol.315 (15), p.1580

2016

Volltextzugriff (PDF)

Hospital discharges for diabetic foot disease in New Zealand: 1980–1993

Diabetes research and clinical practice, 1998, Vol.39 (1), p.69-74

1998

Volltextzugriff (PDF)

Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed Hyperlipidemia

The New England journal of medicine, 2024-09, Vol.391 (10), p.913-925

2024

Volltextzugriff (PDF)

Short-term statin treatment improves endothelial function and neurohormonal imbalance in normocholesterolaemic patients with non-ischaemic heart failure

Heart (British Cardiac Society), 2006-11, Vol.92 (11), p.1603-1609

2006

Volltextzugriff (PDF)

1 – 25 von 520

Suche als RSS-Feed

Aktive Filter

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(490)
Mit Volltextzugriff
(416)

Publikationsform

Artikel
(519)
Tagungsberichte
(1)

Sprache

Englisch
(520)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Relationship of low molecular weight fluorophore levels with clinical factors and fenofibrate effects in adults with type 2 diabetes

Baseline Circulating FGF21 Concentrations and Increase after Fenofibrate Treatment Predict More Rapid Glycemic Progression in Type 2 Diabetes: Results from the FIELD Study

The relationship of fibroblast growth factor 21 with cardiovascular outcome events in the Fenofibrate Intervention and Event Lowering in Diabetes study

Relationship of fibroblast growth factor 21 with baseline and new on-study microvascular disease in the Fenofibrate Intervention and Event Lowering in Diabetes study

Comparison of SSCP and DHPLC for the detection of LDLR mutations in a New Zealand cohort

Relative glycaemic impact of customarily consumed portions of eighty-three foods measured by digesting in vitro and adjusting for food mass and apparent glucose disposal

Comparison of Insulin Resistance, Metabolic Syndrome and Adiponectin in Overweight Bipolar Patients Taking Sodium Valproate and Controls

All-Cause Mortality in the Canterbury (New Zealand) Insulin-Treated Diabetic Registry Population

Cause-specific mortality in insulin-treated diabetic patients: A 20-year follow-up

Predictors of mortality from type 2 diabetes mellitus in Canterbury, New Zealand; a ten-year cohort study

Plasma retinol-binding protein is not a marker of insulin resistance in overweight subjects: A three year longitudinal study

All-cause mortality in insulin-treated diabetic patients: A 20-year follow-up

Homocysteine, glycine betaine, and N, N-dimethylglycine in patients attending a lipid clinic

Relationship between plasma coenzyme Q10 , asymmetric dimethylarginine and arterial stiffness in patients with phenotypic or genotypic familial hypercholesterolemia on long-term statin therapy

A Randomized, Double-Blind, Placebo-Controlled Crossover Study of Coenzyme Q10 Therapy in Hypertensive Patients With the Metabolic Syndrome

Comparative effects of enzogenol® and vitamin C supplementation versus vitamin C alone on endothelial function and biochemical markers of oxidative stress and inflammation in chronic smokers

Variability in measurements of blood glucose response to foods in human subjects is not reduced after a standard breakfast

Considerable temporal variability in glucose reference curves in humans for a year period

PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial

Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease

Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease

Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical Trial

Hospital discharges for diabetic foot disease in New Zealand: 1980–1993

Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed Hyperlipidemia

Short-term statin treatment improves endothelial function and neurohormonal imbalance in normocholesterolaemic patients with non-ischaemic heart failure

Aktive Filter

Suchergebnisse filtern